Stryker (SYK) Cash from Restructuring (2009 - 2010)
Stryker (SYK) reported Cash from Restructuring of $1.0 million for Q4 2010, down 96.96% year-over-year from $32.9 million in Q4 2009, and up 900.0% on a QoQ basis from $100000.0 in Q3 2010.
Stryker (SYK) has 2 years of Cash from Restructuring data on file, last reported at $1.0 million in Q4 2010.
- Quarterly Cash from Restructuring fell 96.96% year-over-year to $1.0 million in Q4 2010, while the trailing twelve-month figure through Dec 2010 was $38.7 million (up 1.57% YoY) and the FY2011 annual result came in at $29.0 million, up 222.22% from the prior year.
- Cash from Restructuring advanced to $1.0 million in Q4 2010 per SYK's latest filing, from $100000.0 in the prior quarter.
- Across five years, Cash from Restructuring topped out at $32.9 million in Q4 2009 and bottomed at $100000.0 in Q3 2010.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 1.00 Mn |
| Sep 30, 2010 | 100,000.00 |
| Dec 31, 2009 | 32.90 Mn |
| Sep 30, 2009 | 4.70 Mn |